Hemas Holdings Statistics
Total Valuation
Hemas Holdings has a market cap or net worth of LKR 93.47 billion. The enterprise value is 90.89 billion.
| Market Cap | 93.47B |
| Enterprise Value | 90.89B |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | Jun 30, 2026 |
Share Statistics
Hemas Holdings has 3.00 billion shares outstanding. The number of shares has increased by 0.50% in one year.
| Current Share Class | 3.00B |
| Shares Outstanding | 3.00B |
| Shares Change (YoY) | +0.50% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 8.26% |
| Owned by Institutions (%) | 7.73% |
| Float | 649.77M |
Valuation Ratios
The trailing PE ratio is 10.85 and the forward PE ratio is 9.75.
| PE Ratio | 10.85 |
| Forward PE | 9.75 |
| PS Ratio | 0.73 |
| PB Ratio | 1.66 |
| P/TBV Ratio | 1.79 |
| P/FCF Ratio | 33.82 |
| P/OCF Ratio | 17.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.89, with an EV/FCF ratio of 32.88.
| EV / Earnings | 10.49 |
| EV / Sales | 0.71 |
| EV / EBITDA | 5.89 |
| EV / EBIT | 6.93 |
| EV / FCF | 32.88 |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.60 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 4.33 |
| Interest Coverage | 11.71 |
Financial Efficiency
Return on equity (ROE) is 17.18% and return on invested capital (ROIC) is 17.64%.
| Return on Equity (ROE) | 17.18% |
| Return on Assets (ROA) | 7.78% |
| Return on Invested Capital (ROIC) | 17.64% |
| Return on Capital Employed (ROCE) | 19.62% |
| Weighted Average Cost of Capital (WACC) | 6.13% |
| Revenue Per Employee | 24.67M |
| Profits Per Employee | 1.68M |
| Employee Count | 5,173 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 3.57 |
Taxes
In the past 12 months, Hemas Holdings has paid 4.20 billion in taxes.
| Income Tax | 4.20B |
| Effective Tax Rate | 31.58% |
Stock Price Statistics
The stock price has increased by +0.65% in the last 52 weeks. The beta is 0.34, so Hemas Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +0.65% |
| 50-Day Moving Average | 31.82 |
| 200-Day Moving Average | 33.12 |
| Relative Strength Index (RSI) | 42.56 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hemas Holdings had revenue of LKR 127.61 billion and earned 8.67 billion in profits. Earnings per share was 2.87.
| Revenue | 127.61B |
| Gross Profit | 41.58B |
| Operating Income | 12.95B |
| Pretax Income | 13.29B |
| Net Income | 8.67B |
| EBITDA | 14.83B |
| EBIT | 12.95B |
| Earnings Per Share (EPS) | 2.87 |
Balance Sheet
The company has 15.18 billion in cash and 11.98 billion in debt, with a net cash position of 3.20 billion or 1.07 per share.
| Cash & Cash Equivalents | 15.18B |
| Total Debt | 11.98B |
| Net Cash | 3.20B |
| Net Cash Per Share | 1.07 |
| Equity (Book Value) | 56.42B |
| Book Value Per Share | 18.46 |
| Working Capital | 26.74B |
Cash Flow
In the last 12 months, operating cash flow was 5.22 billion and capital expenditures -2.45 billion, giving a free cash flow of 2.76 billion.
| Operating Cash Flow | 5.22B |
| Capital Expenditures | -2.45B |
| Depreciation & Amortization | 1.83B |
| Net Borrowing | -2.15B |
| Free Cash Flow | 2.76B |
| FCF Per Share | 0.92 |
Margins
Gross margin is 32.58%, with operating and profit margins of 10.15% and 6.79%.
| Gross Margin | 32.58% |
| Operating Margin | 10.15% |
| Pretax Margin | 10.42% |
| Profit Margin | 6.79% |
| EBITDA Margin | 11.62% |
| EBIT Margin | 10.15% |
| FCF Margin | 2.17% |
Dividends & Yields
This stock pays an annual dividend of 0.95, which amounts to a dividend yield of 3.04%.
| Dividend Per Share | 0.95 |
| Dividend Yield | 3.04% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 34.79% |
| Buyback Yield | -0.50% |
| Shareholder Yield | 2.55% |
| Earnings Yield | 9.27% |
| FCF Yield | 2.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Hemas Holdings is 41.60, which is 33.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 41.60 |
| Price Target Difference | 33.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on April 29, 2025. It was a forward split with a ratio of 5.
| Last Split Date | Apr 29, 2025 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |